Claire Fournié

Claire Fournié

Auto-generated profile, based on publicly available information

Claire Fournié

Laboratoire IRISSE EA4075, UFR des Sciences de l’Homme et de l’Environnement, Université de la Réunion, Le Tampon, La Réunion, France

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2021 in Complementary Therapies in Medicine
Verified
Journal Article
Open access
CFClaire Fournié
Claire Fournié
FCFlorian Chouchou
Florian Chouchou
GDGeorges Dalleau
Georges Dalleau
Teddy CaderbyTeddy Caderby
Teddy Caderby
QCQuentin Cabrera
Quentin Cabrera
CVChantal Verkindt
Chantal Verkindt
Heart rate variability biofeedback (HRVB) is a non-pharmacological intervention used in the management of chronic diseases. A systematic search was performed according to eligibility criteria including adult chronic patients, HRVB as main treatment with or without control conditions, and psychophysiological outcomes as dependent variables. In total, 29 articles were included. Reported results showed the feasibility of HRVB in chronic patients without adverse effects. Significant positive effects were found in various patient profiles on hypertension and cardiovascular prognosis, inflammatory state, asthma disorders, depression and anxiety, sleep disturbances, cognitive performance and pain, which could be associated with improved quality of life. Improvements in clinical outcomes co-occurred with improvements in heart rate variability, suggesting possible regulatory effect of HRVB on autonomic function. HRVB could be effective in managing patients with chronic diseases. Further investigations are required to confirm these results and recommend the most effective method.

12 October 2021 in Supportive Care in Cancer
Verified
Journal Article
Open access
PDF file
CFClaire Fournié
Claire Fournié
CVChantal Verkindt
Chantal Verkindt
GDGeorges Dalleau
Georges Dalleau
NBNicolas Bouscaren
Nicolas Bouscaren
CMCatherine Mohr
Catherine Mohr
QCQuentin Cabrera
Quentin Cabrera
Purpose: Hematologic patients have a poorer health-related quality of life due to the disease and its treatments. Non-pharmacological interventions represent an opportunity in tertiary cancer prevention to manage persistent symptoms and support patients in their return to active daily living. This interventional study aimed to evaluate the feasibility of a program combining physical exercise (PE) and heart rate variability biofeedback (HRVB) in hematologic patients. Method: Hematologic patients in remission within 6 months participated in a 12-week rehabilitation program including 24 supervised sessions of PE associated with 10 supervised sessions of HRVB and daily home-based practice of paced breathing. We assessed patient adherence, fatigue, physical function, and heart rate variability. Results: Twenty patients were included, 17 completed the protocol and 3 dropped out due to disease progression or time constraints; no adverse events or incidents were reported. Participation rates were 85% for PE and 98% for HRVB-supervised sessions. Significant improvements of physical capacity (6-min walk test, p < 0.001; 50-foot walk test, p < 0.001), muscle strength (grip force test, p < 0.01), and flexibility (toe-touch test, p < 0.001; back scratch test, p < 0.05) were measured. Coherence ratio (p < 0.001) and low-frequency spectral density of HRV signal (p < 0.003) increased significantly, suggesting improved autonomic function. Fatigue, static balance, and other time and frequency indicators of HRV were not improved (all p > 0.05). Conclusion: A rehabilitation program combining PE and HRVB is feasible in hematologic patients and effective on physical function. Further research with a larger sample size is needed to investigate effectiveness on patients’ autonomic functions and their impacts on symptomatology.

14 March 2020 in BMC Sports Science, Medicine and Rehabilitation
Verified
Journal Article
Open access
PDF file
CFClaire Fournié
Claire Fournié
NBNicolas Bouscaren
Nicolas Bouscaren
GDGeorges Dalleau
Georges Dalleau
VLVictorine Lenclume
Victorine Lenclume
CMCatherine Mohr
Catherine Mohr
CVChantal Verkindt
Chantal Verkindt
Background: Hematologic malignancies and their treatments are recognized for their significant long-term adverse effects on health-related quality of life. As a part of cancer treatment, physical exercise is known to improve physical functioning, but there are still questions regarding its impact on psychological and emotional functioning. Nonetheless, heart rate variability biofeedback (HRVB) is recognized for its positive effects on autonomic nervous system balance and emotional self-regulation. The Adapted Physical Activity and Cardiac Coherence in Hematologic Patients (APACCHE) protocol is a randomized, controlled superiority trial designed to evaluate the effects of HRBV training combined with an adaptive physical activity (APA) program compared to APA alone on the post-treatment quality of life of adult hematologic patients. Methods: Seventy patients aged 18–70 years, with various forms of hematological malignancies, in post-treatment remission within six months prior to beginning the study and who have been prescribed APA by a hematologist, will be randomly allocated in a 1:1 ratio to two 12-week treatment groups: HRVB + APA versus APA alone. APA sessions will consist of aerobic and resistance training for 1-h twice weekly. The HRVB training will consist of controlled breathing exercises with biofeedback of heart rate variability for 10 sessions and will include a daily home-based practice. The primary outcome will be to evaluate health-related quality of life (QLQ-C30, SF-36). The secondary outcomes will be to evaluate fatigue (MFI-20); anxiety and depression (HADS); clinical status with blood pressure, progression-free survival, overall survival, and body mass index; heart rate variability level and cardiac coherence score. All of these assessments will be evaluated initially (T1), 6 weeks after (T2), at the end of the 12 weeks (T3), and then at a 12-week post-intervention follow-up (T4). Discussion: To our knowledge, this is the first protocol to investigate the additional value of HRVB on physical exercise. In addition, there has been no study previously published about HRVB in hematologic patients. We hypothesize that overall quality of life and psychological and physical functioning will be improved, potentially offering a better understanding of supportive cancer care in hematology and inferring new perspectives in psychophysiological research in cancer. Trial registration: Current randomized controlled trial was registered 29 November 2017 on Clinical Trials.gov (NCT number: NCT03356171).

4 April 2026
Verified
Thesis
Closed access
CFClaire Fournié
Claire Fournié
Introduction : Les cancers hématologiques sont de survenues brutales et nécessitent des traitements agressifs, notamment de la chimiothérapie intensive et parfois des greffes de cellules souches hématopoïétiques. Les répercussions induites par le cancer et ses traitements sont responsables d’une altération majeure de la qualité de vie, autant qu’une fatigue chronique et des difficultés de réadaptation sociales et professionnelles. Les programmes d’Activité Physique Adaptée (APA) en hématologie ont montré leur efficacité sur l’état physique et la fatigue principalement mais restent peu concluants sur les dimensions psycho-émotionnelles de la qualité de vie. Des recherches récentes en neuro-cardiologie ont par ailleurs montré les bénéfices d’un entraînement à la Cohérence Cardiaque (CC) sur l’équilibre du Système Nerveux Autonome (SNA) et sur l’état psycho-émotionnel. Méthode : Les travaux de recherche entrepris dans cette thèse ont pour objectifs d’évaluer les effets d’une intervention non-médicamenteuse sur la qualité de vie de patients adultes en post-traitement d’une hémopathie maligne. La récupération d’un équilibre physiologique est indexée par la Variabilité de la Fréquence Cardiaque (VFC), reconnue comme une fenêtre d’observation du SNA. Nous présentons quatre études : une étude expérimentale auprès de sujets sains pour mieux comprendre les mécanismes de la VFC lors d’une respiration lente et profonde ; une étude de faisabilité portant sur la mise en œuvre d’un programme APA en hématologie ; puis les résultats préliminaires d’un essai contrôlé randomisé évaluant les effets d’un programme combinant APA et CC sur la VFC, la qualité de vie, la fatigue et l’état anxiodépressif ; et enfin une étude qualitative évaluant le déroulement du programme et les effets des deux interventions. Résultats : Nos résultats montrent d’abord la faisabilité de l’APA et de la CC chez ces patients. Même si les résultats portant sur l’analyse de la VFC sont difficiles à interpréter avec précision, ils tendent à confirmer qu’une intervention en CC entraîne une stimulation du tonus vagal. L’évaluation qualitative nous apporte de nombreux éléments déterminants dans l’adéquation entre les interventions et les besoins singuliers des patients et dans leur efficacité sur l’optimisation d’un retour à une vie active et autonome. Discussion : Ces travaux de recherche apportent par de nouveaux faits expérimentaux, des éléments supplémentaires dans la compréhension des mécanismes de la CC et de ses applications en milieu clinique. D’autres expérimentations sont encore nécessaires pour approfondir nos connaissances dans le cadre d’une approche psychophysiologique en APA et cancer.